Showing results for "BIOS" in Computer Science

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.

When molecular biologist Becky McClain raised urgent alarms about biosafety lapses at her biotech lab at Pfizer, she expected concern—not retaliation. Instead, her warnings about dangerous, genetically engineered viruses that were handled without following standard safety protocols were met with hostility, intimidation, and ultimately, devastating illness after a workplace exposure changed her life forever.

In Frankenstein's Cat, journalist Emily Anthes takes us from petri dish to pet store as she explores how biotechnology is shaping the future of our furry and feathered friends. Through her encounters with scientists, conservationists, ethicists, and entrepreneurs, Anthes reveals that while some of our interventions may be trivial (behold: the GloFish), others could improve the lives of many species - including our own. So what does biotechnology really mean for the world's wild things? And what do our brave new beasts tell us about ourselves?

The Next Decade of Biotech is a sweeping exploration of how biotechnology is transforming health, food, industry, and the environment. It covers breakthroughs like CRISPR, mRNA vaccines, and synthetic biology, and examines the integration of biotech with AI, robotics, and quantum computing. The book highlights how biotech is enabling personalized medicine, sustainable agriculture, regenerative materials, and ecological restoration. It also addresses critical ethical challenges—gene editing, data privacy, access, and environmental risk—and urges inclusive, democratic governance.

The Apples, Amazons and Googles of the next few decades will be biotech companies. The tech companies of the last few years have changed how we do things but the businesses driving the biotech revolution are about making life better. These companies will solve many of our most intractable problems: cancer, dementia, diabetes, elderly care, mental health challenges, even power generation and agricultural production. The audiobook explains what biotech is, what is coming next, and in a final section, how interested investors can profit from it.